BusinessCrown Bioscience to Showcase Scientific Expertise in Preclinical Evaluation of Investigational Cancer Compounds at the American Association for Cancer Research’s International Conference on Molecular Targets and Cancer TherapeuticsBy Nasdaq OMXOct 17, 2017, 1:51 PM UTC
BusinessCrownBio’s Integrated Oncology Platform Helps Advance Apogenix’s Promising HERA-GITRL Immunotherapy for NSCLC and Head and Neck CancerBy Nasdaq OMXSep 13, 2017, 2:04 PM UTC
BusinessCrownBio Launches Innovative Inflammatory Disease Models to Advance Pre-Clinical ResearchBy Nasdaq OMXAug 1, 2017, 12:00 PM UTC
BusinessCrownBio Demonstrates Scientific Advancements in Metabolic Disease with a validated and improved translatable model for obesity and Type 2 Diabetes drug discoveryBy Nasdaq OMXJul 6, 2017, 12:00 PM UTC
